Benjamin L. Ebert
M.D., Ph.D.
Chair, Department of Medical Oncology
👥Biography 个人简介
Benjamin Ebert is a leader in hematologic malignancy research who has made fundamental discoveries about myelodysplastic syndromes and clonal hematopoiesis. His work has characterized the genetic basis of MDS and the clinical implications of clonal hematopoiesis of indeterminate potential (CHIP).
Benjamin Ebert是血液恶性肿瘤研究的领导者,在骨髓增生异常综合征和克隆性造血方面做出了基础性发现。他的工作描述了MDS的遗传基础和不确定潜能克隆性造血(CHIP)的临床意义。
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
MDS Genetics
Characterized genetic basis of myelodysplastic syndromes.
CHIP
Defined clinical implications of clonal hematopoiesis.
Representative Works 代表性著作
Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence
New England Journal of Medicine (2014)
CHIP and cancer risk.
📄Data Sources 数据来源
Last updated: 2026-03-05 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Benjamin L. Ebert 的研究动态
Follow Benjamin L. Ebert's research updates
留下邮箱,当我们发布与 Benjamin L. Ebert(Dana-Farber Cancer Institute)相关的新研究或访谈时,我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment